Drug Shortages

Below is a list of current and anticipated ophthalmic drug shortages. This table is generated from Health Canada and is intended for use by practicing ophthalmologists. Drugs that have been out of production or unavailable for more than 12 months are not included in this table.

The table is updated daily.

Submission to Health Canada’s Consultation on Improving Access to Drugs and Other Health Products

Ophthalmic Essential Medication List for Canada

Last Updated: 2024-06-17 00:01:33

Drug Name Drug Status Last Updated DIN Type Anticipated Start Date Estimated End Date Actual Start Date Actual End Date Shortage Reason
MED-BRIMONIDINE Marketed 2020-12-09 02507811 Shortage 2022-08-01 2022-11-15 2022-08-08 Demand increase for the drug.
OXERVATE Dormant 2022-05-08 02485613 Shortage 2023-08-30 Other (Please describe in comments)
OXERVATE Dormant 2022-05-08 02485613 Shortage 2023-08-30 Other (Please describe in comments)
APO-DICLOFENAC OPHTHALMIC Marketed 2023-12-19 02441020 Shortage 2023-07-11 Disruption of the manufacture of the drug.
APO-OLOPATADINE Marketed 2024-03-09 02402823 Shortage 2024-03-26 Disruption of the manufacture of the drug.
DIOFLUOR STRIPS Marketed 2023-11-16 02160773 Shortage 2020-12-01 2025-04-30 2021-03-22 Disruption of the manufacture of the drug.
MINIMS FLUORESCEIN SODIUM Marketed 2023-11-16 02148390 Shortage 2024-06-10 2024-06-21 2024-06-10 Delay in shipping of the drug.
ACT LATANOPROST/TIMOLOL Marketed 2024-02-09 02436256 Shortage 2021-08-27 Disruption of the manufacture of the drug.
APO-TIMOP Marketed 2018-03-08 00755834 Shortage 2024-07-05 2024-01-02 Disruption of the manufacture of the drug.
ATROPINE Marketed 2024-02-09 02023695 Shortage 2020-11-01 Delay in shipping of the drug.
CYCLOGYL Marketed 2024-02-09 00252506 Shortage 2022-11-08 2024-06-30 2022-11-08 Requirements related to complying with good manufacturing practices.
JAMP-MOXIFLOXACIN Marketed 2024-03-09 02472120 Shortage 2024-10-15 2023-10-16 Disruption of the manufacture of the drug.
JAMP-OLOPATADINE Marketed 2024-02-09 02458411 Shortage 2024-12-31 2023-08-24 Other (Please describe in comments)
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION Marketed 2022-06-08 02489368 Shortage 2023-06-26 Demand increase for the drug.
ODAN-TROPICAMIDE Marketed 2024-02-09 00622885 Shortage 2024-10-11 2024-04-22 Disruption of the manufacture of the drug.
PDP-ERYTHROMYCIN Marketed 2020-04-03 01912755 Shortage 2024-08-01 2024-05-03 Shortage of an inactive ingredient or component.
SANDOZ BRIMONIDINE Marketed 2024-05-09 02305429 Shortage 2024-06-28 2024-06-12 Disruption of the manufacture of the drug.
SANDOZ TIMOLOL Marketed 2024-02-09 02166712 Shortage 2024-07-05 2024-04-23 Disruption of the manufacture of the drug.
TEVA-CYCLOSPORINE Marketed 2024-03-09 02462486 Shortage 2024-07-20 2024-05-15 Disruption of the manufacture of the drug.
TEVA-LATANOPROST Marketed 2024-02-09 02254786 Shortage 2024-12-20 2024-02-07 Disruption of the manufacture of the drug.
TEVA-LATANOPROST Marketed 2024-02-09 02254786 Shortage 2024-12-20 2024-05-08 Disruption of the manufacture of the drug.
TIMOLOL MALEATE-EX Marketed 2023-12-19 02242275 Shortage 2024-07-28 2024-05-13 Disruption of the manufacture of the drug.
TRAVATAN Z Marketed 2024-02-09 02318008 Shortage 2024-06-11 2024-06-21 2024-06-11 Delay in shipping of the drug.
VISTITAN Marketed 2024-03-09 02429063 Shortage 2024-07-05 2024-03-05 Shortage of an active ingredient.

- Minimize

+ Maximize

:
: